NAV
$36.18
AUM
$76.4M
Expense Ratio
-
Dividend Yield
0.00%
Beta
0.79
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +7.43% | +4.84% | +4.34% | +10.87% | +15.50% | - |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | DVA | DaVita Inc | 2.54% |
| 2 | TER | Teradyne Inc | 2.40% |
| 3 | VRSN | VeriSign Inc | 2.35% |
| 4 | FOXA | Fox Corp Class A | 2.14% |
| 5 | DXCM | DexCom Inc | 2.05% |
| 6 | MO | Altria Group Inc | 2.04% |
| 7 | PLTR | Palantir Technologies Inc Ordinary Shares - Class A | 2.01% |
| 8 | SWK | Stanley Black & Decker Inc | 2.00% |
| 9 | INCY | Incyte Corp | 1.95% |
| 10 | CIEN | Ciena Corp | 1.94% |
The fund is an actively-managed exchange-traded fund (“ETF”) that seeks to achieve its objective by investing principally in the common stocks of U.S. and non-U.S. companies interested in influencing public policy through their lobbying activity in Washington D.C. Strategas Asset Management, LLC (the “Adviser”) considers lobbying a nontraditional and largely unrecognized factor in company analysis. It may, from time to time, invest a significant portion of its total assets in securities of companies in certain sectors or located in particular countries or regions outside the U.S.
Inception Date: 2022-01-25